KNBIF (Kane Biotech) Institutional Ownership: 0.65% (As of Jun. 27, 2026)


What is Kane Biotech Institutional Ownership?

Kane Biotech KNBIF Institutional Ownership is 0.65% as of Jun. 27, 2026. The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Kane Biotech's institutional ownership is 0.65%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Kane Biotech's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Kane Biotech's Float Percentage Of Total Shares Outstanding is 0.00%.

Kane Biotech Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Kane Biotech's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Institutional Ownership Chart

Kane Biotech Historical Data

The historical data trend for Kane Biotech can be seen below:

2015-11-30 2015-12-31 2016-01-31 2016-02-29 2016-03-31 2016-04-30 2016-05-31 2016-06-30 2016-07-31 2016-08-31
Institutional Ownership 1.15 1.09 1.09 1.09 1.05 1.05 1.05 0.65 0.65 0.65

Kane Biotech Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.65% mean?
Kane Biotech (KNBIF) has a Institutional Ownership of 0.65% as of Jun. 27, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Kane Biotech and its competitors.
Is Kane Biotech's Institutional Ownership too high?
Kane Biotech's current Institutional Ownership is 0.65%.
How does Kane Biotech's Institutional Ownership compare to VRTX and REGN?
Kane Biotech's Institutional Ownership of 0.65% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Kane Biotech and its competitors. Kane Biotech's current Institutional Ownership is 0.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current Institutional Ownership of 0.65%. The current Institutional Ownership is 0.65%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current Institutional Ownership is 0.65% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.